Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Bibliographic Details
Main Authors:	Schilling, Bastian, Schneider, Tim, Möller, Inga, Sucker, Antje, Paschen, Annette, Schadendorf, Dirk, Griewank, Klaus G
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315232/

Similar Items

Lack of SF3B1 R625 mutations in cutaneous melanoma
by: Schilling, Bastian, et al.
Published: (2013)

Analysis of SDHD promoter mutations in various types of melanoma
by: Scholz, Simone L., et al.
Published: (2015)

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
by: Zimmer, Lisa, et al.
Published: (2015)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
by: Griewank, K G, et al.
Published: (2013)

Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells
by: Schilling, Bastian, et al.
Published: (2013)

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
by: Griewank, Klaus G., et al.
Published: (2013)

Long-Term Survivors with Metastatic Uveal Melanoma
by: Buzzacco, Dominic M, et al.
Published: (2012)

Uveal Melanoma
by: Papastefanou, Vasilios P., et al.
Published: (2011)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
by: Demirci, Hakan, et al.
Published: (2013)

Corticosteroids and immune checkpoint blockade
by: Min, Le, et al.
Published: (2015)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
by: Thilo Gambichler, et al.
Published: (2017-05-01)

Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
by: Cooper, Zachary A, et al.
Published: (2014)

Uveal melanoma: Estimating prognosis
by: Kaliki, Swathi, et al.
Published: (2015)

YAP as oncotarget in uveal melanoma
by: Yu, Fa-Xing, et al.
Published: (2014)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
by: Gangemi, Rosaria, et al.
Published: (2012)

Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
by: Buder, Kristina, et al.
Published: (2013)

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
by: Valpione, Sara, et al.
Published: (2015)

Immune checkpoint blockade in ovarian cancer
by: Weiss, Lukas, et al.
Published: (2016)

Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)
by: Kim, Dae Won, et al.
Published: (2015)

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
by: Lüke, Julia, et al.
Published: (2016)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
by: Margaret M. Reynolds, et al.
Published: (2017-05-01)

Molecular Bases of Cutaneous and Uveal Melanomas
by: Gaudi, Sudeep, et al.
Published: (2011)

Expression of EpCAM in uveal melanoma
by: Odashiro, Danilo N, et al.
Published: (2006)

Proteomics of Uveal Melanoma: A Minireview
by: Abildgaard, Søren K. O., et al.
Published: (2013)

The genetics of uveal melanoma: current insights
by: Helgadottir, Hildur, et al.
Published: (2016)

Upcoming translational challenges for uveal melanoma
by: Nabil, Amirouchene-Angelozzi, et al.
Published: (2015)

Upcoming translational challenges for uveal melanoma
by: Amirouchene-Angelozzi, Nabil, et al.
Published: (2015)

Prognostic value of legumain in uveal melanoma
by: WU, TONG, et al.
Published: (2016)

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients
by: Schrama, David, et al.
Published: (2014)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
by: Kim, Teresa, et al.
Published: (2014)

Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials
by: Petrelli, Fausto, et al.
Published: (2016)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Ahn, Brian J., et al.
Published: (2013)

Immune checkpoint blockade therapy for bladder cancer treatment
by: Kim, Jayoung
Published: (2016)

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
by: Swart, Maarten, et al.
Published: (2016)

Update on checkpoint blockade therapy for lymphoma
by: Kline, Justin, et al.
Published: (2015)

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
by: Crabb, John W., et al.
Published: (2015)

The role of c-kit and imatinib mesylate in uveal melanoma
by: Pereira, Patricia Rusa, et al.
Published: (2005)

Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma
by: Fernandes, Bruno F, et al.
Published: (2007)

Combined treatment of uveal melanoma liver metastases
by: Brasiuniene, B, et al.
Published: (2011)

Repression of genes involved in melanocyte differentiation in uveal melanoma
by: Bergeron, Marjorie-Allison, et al.
Published: (2012)